dr. Natalie Trump

Dr. Natalie Trump is a Clinical Scientist at Congenica, based at the Wellcome Genome Campus, Cambridge, UK.

 

Natalie gained her PhD in genetics from the University of Birmingham and then went on to spend 10 years working in the NHS as a Clinical Scientist. Whilst at Great Ormond Street Hospital Natalie set up a new epilepsy service using gene panel analysis. This new diagnostic service improved diagnostic yield and broadened the phenotypes associated with developmental and epileptic encephalopathies (Trump et al, 2016).

 

Natalie then spent 2 years as a postdoctoral researcher at UCL working on gene discovery in early onset childhood movement and epilepsy disorders before moving to Congenica in 2020.

 

At Congenica Natalie works in a team providing a genomic interpretation service. Natalie brings expertise in the epilepsy field to Congenica and has recently completed a re-analysis project of previously unsolved epilepsy cases. The discovery of biallelic CRELD1 variants causing a newly identified CRELD1-related disorder was the catalyst for this project.